These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 25063062)

  • 1. Effects of mTOR-STAT3 on the migration and invasion abilities of hepatoma cell and mTOR-STAT3 expression in liver cancer.
    Pu X; Guo QX; Long HA; Yang CW
    Asian Pac J Trop Med; 2014 May; 7(5):368-72. PubMed ID: 25063062
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [IL-12 induces autophagy via AKT/mTOR/STAT3 signaling pathway in human hepatoma cells].
    Liu C; Xie C; Lin Y; Wu B; Wang Q; Li Z; Tu Z
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2016 Jul; 32(7):870-5. PubMed ID: 27363263
    [TBL] [Abstract][Full Text] [Related]  

  • 3. STAT3 regulates glycolysis via targeting hexokinase 2 in hepatocellular carcinoma cells.
    Li M; Jin R; Wang W; Zhang T; Sang J; Li N; Han Q; Zhao W; Li C; Liu Z
    Oncotarget; 2017 Apr; 8(15):24777-24784. PubMed ID: 28445971
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transforming growth factor β1 promotes migration and invasion in HepG2 cells: Epithelial‑to‑mesenchymal transition via JAK/STAT3 signaling.
    Lin XL; Liu M; Liu Y; Hu H; Pan Y; Zou W; Fan X; Hu X
    Int J Mol Med; 2018 Jan; 41(1):129-136. PubMed ID: 29115395
    [TBL] [Abstract][Full Text] [Related]  

  • 5. miR-345 inhibits tumor metastasis and EMT by targeting IRF1-mediated mTOR/STAT3/AKT pathway in hepatocellular carcinoma.
    Yu M; Xue H; Wang Y; Shen Q; Jiang Q; Zhang X; Li K; Jia M; Jia J; Xu J; Tian Y
    Int J Oncol; 2017 Mar; 50(3):975-983. PubMed ID: 28098858
    [TBL] [Abstract][Full Text] [Related]  

  • 6. mTORC1 Up-Regulates GP73 to Promote Proliferation and Migration of Hepatocellular Carcinoma Cells and Growth of Xenograft Tumors in Mice.
    Chen X; Wang Y; Tao J; Shi Y; Gai X; Huang F; Ma Q; Zhou Z; Chen H; Zhang H; Liu Z; Sun Q; Peng H; Chen R; Jing Y; Yang H; Mao Y; Zhang H
    Gastroenterology; 2015 Sep; 149(3):741-52.e14. PubMed ID: 25980751
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Knockdown of STAT3 inhibits proliferation and migration of HepG2 hepatoma cells induced by IFN1].
    Li X; Wang Y; Yan B; Fang P; Ma C; Xu N; Fu X; Liang S
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2018 Feb; 34(2):115-122. PubMed ID: 29673453
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA-224 is upregulated in HepG2 cells and involved in cellular migration and invasion.
    Li Q; Wang G; Shan JL; Yang ZX; Wang HZ; Feng J; Zhen JJ; Chen C; Zhang ZM; Xu W; Luo XZ; Wang D
    J Gastroenterol Hepatol; 2010 Jan; 25(1):164-71. PubMed ID: 19793168
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suppressive effects of microRNA-16 on the proliferation, invasion and metastasis of hepatocellular carcinoma cells.
    Wu WL; Wang WY; Yao WQ; Li GD
    Int J Mol Med; 2015 Dec; 36(6):1713-9. PubMed ID: 26499886
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Inhibitory effect and molecular mechanism of sinomenine on human hepatocellular carcinoma HepG2 and SK-HEP-1 cells].
    Tian YY; Ma BB; Zhao XY; Liu C; Li YL; Yu SY; Tian SQ; Pei HL; Lyu YN; Zuo ZP; Wang ZB
    Zhongguo Zhong Yao Za Zhi; 2023 Sep; 48(17):4702-4710. PubMed ID: 37802809
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cucurbitacin I exhibits anticancer efficacy through induction of apoptosis and modulation of JAK/STAT3, MAPK/ERK, and AKT/mTOR signaling pathways in HepG2 cell line.
    Üremiş N; Üremiş MM; Çiğremiş Y; Tosun E; Baysar A; Türköz Y
    J Food Biochem; 2022 Oct; 46(10):e14333. PubMed ID: 35866877
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protrusion-localized STAT3 mRNA promotes metastasis of highly metastatic hepatocellular carcinoma cells in vitro.
    Liu YH; Jin JL; Wang YZ; Tan Y; Zhou YY; Peng T; Li F; Liang WD; Chartrand P; Jiang YY; Shen ZF
    Acta Pharmacol Sin; 2016 Jun; 37(6):805-13. PubMed ID: 27133294
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ADAM10 is overexpressed in human hepatocellular carcinoma and contributes to the proliferation, invasion and migration of HepG2 cells.
    Yuan S; Lei S; Wu S
    Oncol Rep; 2013 Oct; 30(4):1715-22. PubMed ID: 23912592
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Upregulation of miR-129-5p affects laryngeal cancer cell proliferation, invasiveness, and migration by affecting STAT3 expression.
    Shen N; Huang X; Li J
    Tumour Biol; 2016 Feb; 37(2):1789-96. PubMed ID: 26318305
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effect of Tip30 expression on the invasion and metastasis of hepatoma cells].
    Li H; Wu J; Jiang B; Liang Z
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2014 Aug; 39(8):775-83. PubMed ID: 25202945
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of HMGB1 on invasion and migration of human hepatoma cell line HepG2 and its mechanism].
    Wang C; Tang C; Chang X; Li Z
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2013 Nov; 29(11):1159-62. PubMed ID: 24200063
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Downregulation of Notch1 inhibits the invasion of human hepatocellular carcinoma HepG2 and MHCC97H cells through the regulation of PTEN and FAK.
    Hu YJ; Li HY; Qiu KJ; Li DC; Zhou JH; Hu YH; Zhang FM
    Int J Mol Med; 2014 Oct; 34(4):1081-6. PubMed ID: 25110169
    [TBL] [Abstract][Full Text] [Related]  

  • 18. STAT3 cooperates with Twist to mediate epithelial-mesenchymal transition in human hepatocellular carcinoma cells.
    Zhang C; Guo F; Xu G; Ma J; Shao F
    Oncol Rep; 2015 Apr; 33(4):1872-82. PubMed ID: 25653024
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Notch1 downregulation combined with interleukin-24 inhibits invasion and migration of hepatocellular carcinoma cells.
    Han B; Liu SH; Guo WD; Zhang B; Wang JP; Cao YK; Liu J
    World J Gastroenterol; 2015 Sep; 21(33):9727-35. PubMed ID: 26361419
    [TBL] [Abstract][Full Text] [Related]  

  • 20. S100A4 regulates migration and invasion in hepatocellular carcinoma HepG2 cells via NF-κB-dependent MMP-9 signal.
    Zhang J; Zhang DL; Jiao XL; Dong Q
    Eur Rev Med Pharmacol Sci; 2013 Sep; 17(17):2372-82. PubMed ID: 24065232
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.